ENW EnWave Corporation

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN
THE UNITED STATES


EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
is pleased to announce that it has priced, together with Raymond James Ltd. (the
"Lead Agent"), on behalf of a syndicate of Agents including CIBC (the "Agents"),
its previously announced best efforts private placement for gross proceeds of
between $7.5 million to $10.0 million (the "Offering").


Pursuant to the Offering, the Company will issue up to 7,142,855 units (each a
"Unit") at a price of $1.40 per Unit. Each Unit will be comprised of one common
share of the Company (a "Common Share") and one half of one common share
purchase warrant (a "Warrant"). Each whole Warrant will entitle the holder to
purchase one common share of the Company at a price of $1.75 for a period of 24
months following the Closing Date (as defined below). The commission payable to
the Agents remains as previously disclosed.


The net proceeds from the Offering shall be used to finance the production of
several Radiant Energy Vacuum ("REV(TM)") machines associated with confirmed
royalty-bearing commercial licenses, and for expanded sales and marketing
efforts, focused research and development, working capital and general corporate
purposes.


Closing of the Offering is scheduled to occur on or about December 20, 2013 (the
"Closing Date"). All securities issued by EnWave in connection with this
Offering will be subject to a statutory four month hold period. Completion of
the Offering is subject to a number of conditions, including, without
limitation, receipt of all regulatory approvals, including approval of the TSX
Venture Exchange.


This news release does not constitute an offer to sell, or a solicitation of an
offer to buy, any of the securities in the United States. The securities have
not been and will not be registered under the United States Securities Act of
1933, as amended (the "U.S. Securities Act") or any state securities laws and
may not be offered or sold within the United States or to U.S. Persons unless
registered under the U.S. Securities Act and applicable state securities laws or
an exemption, as defined in the U.S. Securities Act such registration is
available.


About EnWave

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV(TM))
dehydration technology. EnWave aims to sign royalty-bearing commercial licenses
with leading food and pharmaceutical companies for the use of its revolutionary
technology. Thus far the Company has signed commercial licenses with Bonduelle,
a global leader in the production of vegetables, for the processing of
dehydrofrozen vegetables; Hormel Foods Corporation, a major processed meat
manufacturer, for the production of healthy dried meat products; Milne Fruit
Product, EnWave's first major licensee, for the production of several dehydrated
fruit and vegetable products in the whole, fragmented and powdered form; a
leading North American enzyme company, to dehydrate a series of food-related
enzymes for their Tier 1 clients; and Napa Mountain Spice Company, to dry
high-quality California bay leaves. In addition to these licenses, EnWave has
formed a Limited Liability Partnership with Lucid Capital Management to develop,
manufacture, market and sell all-natural cheese snack products in the United
States under the Moon Cheese(R) brand.


Also, EnWave has entered into a wide range of research and collaboration
agreements with an expanding list of multinational companies. EnWave is
introducing REV(TM) as a new dehydration standard in the food and biological
material sectors: potentially faster and cheaper than freeze drying, with better
end product quality than air drying or spray drying.


EnWave currently has six REV(TM) platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry fruits, vegetables, meat, herbs
and seafood quickly and at low-cost, while maintaining high levels of nutrition,
taste, texture and colour. The Company is also developing powderREV(TM) for bulk
dehydration of food cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of pastes,
gels, liquids, or particulates; and bioREV(TM) and freezeREV(TM) as new methods
to stabilize and dehydrate biopharmaceuticals such as vaccines and antibodies.
More information about EnWave is available at www.enwave.net.


EnWave Corporation

Dr. Tim Durance, Chairman & Co-CEO

Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the offering, the
closing of the Offering, the expected outcome of the Offering, the Company's
strategy for growth, product development, market position, expected
expenditures, and the expected synergies following the closing are
forward-looking statements. All third party references to market information in
this release are not guaranteed to be accurate as the Company did not conduct
the original primary research. These statements are not a guarantee of future
performance and involve a number of risks, uncertainties and assumptions.
Although the Company has attempted to identify important factors that could
cause actual results to differ materially, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can be no
assurance that such statements will prove to be accurate, as actual results and
future events could differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking
statements.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
EnWave Corporation
Mr. John McNicol
President & Co-CEO
(604) 601-8524
john.mcnicol@enwave.net


EnWave Corporation
Mr. Brent Charleton
Vice President, Corporate Affairs
(778) 378-9616
bcharleton@enwave.net
www.enwave.net

EnWave (TSXV:ENW)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

EnWave (TSXV:ENW)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024